Chromatographic behaviour predicts the ability of potential nootropics to permeate the blood-brain barrier.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F13%3A43872326" target="_blank" >RIV/62157124:16370/13:43872326 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.3797/scipharm.1208-19" target="_blank" >http://dx.doi.org/10.3797/scipharm.1208-19</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3797/scipharm.1208-19" target="_blank" >10.3797/scipharm.1208-19</a>
Alternative languages
Result language
angličtina
Original language name
Chromatographic behaviour predicts the ability of potential nootropics to permeate the blood-brain barrier.
Original language description
The log BB parameter is the logarithm of the ratio of a compound's equilibrium concentrations in the brain tissue versus the blood plasma. This parameter is a useful descriptor in assessing the ability of a compound to permeate the blood-brain barrier. The aim of this study was to develop a Hansch-type linear regression QSAR model that correlates the parameter log BB and the retention time of drugs and other organic compounds on a reversed-phase HPLC containing an embedded amide moiety. The retention time was expressed by the capacity factor log k'. The second aim was to estimate the brain's absorption of 2-(azacycloalkyl)acetamidophenoxyacetic acids, which are analogues of piracetam, nefiracetam, and meclofenoxate. Notably, these acids may be novel nootropics. Two simple regression models that relate log BB and log k' were developed from an assay performed using a reversed-phase HPLC that contained an embedded amide moiety. Both the quadratic and linear models yielded statistical para
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Scientia Pharmaceutica
ISSN
0036-8709
e-ISSN
—
Volume of the periodical
81
Issue of the periodical within the volume
1
Country of publishing house
AT - AUSTRIA
Number of pages
11
Pages from-to
81-91
UT code for WoS article
—
EID of the result in the Scopus database
—